Diabetes Medications and Risk of Parkinsons Disease: A Cohort Study of Patients With Diabetes
Mechanism of Action in Weight Loss GLP-1 receptor agonists work primarily by reducing appetite and increasing satiety
For research teams working with Retatrutide, it is an indispensable resource that saves time, prevents mistakes, and ensures data integrity
Research presented at Heart Rhythm 2026 followed more than 13,000 patients and found GLP-1 medication use tied to a lower risk of atrial fibrillation, regardless of how much weight patients lost, including patients who gained weight
Our Philosophy We don't believe in miracle solutions or short-lived trends
Between 2021 and 2024, global sales of Ozempic surged from US$5.3bn to US$18.9bn, while Wegovy amassed global sales of US$9.2bn